Lilly (Eli) vs Apple

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (88 vs 91)
Lilly (Eli) logo

Lilly (Eli)

LeaderHealthcare Tech

Enterprise

Indianapolis pharma leader (NYSE: LLY) $45.1B FY2024 revenue (+32%); Mounjaro $11.4B + Zepbound $4.9B tirzepatide GLP-1, oral orforglipron Phase 3, $18B manufacturing expansion competing with Novo Nordisk.

AI VisibilityBeta
Overall Score
A88
Category Rank
#125 of 290
AI Consensus
51%
Trend
stable
Per Platform
ChatGPT
89
Perplexity
79
Gemini
99

About

Eli Lilly and Company is an Indianapolis, Indiana-based global pharmaceutical company — publicly traded on the New York Stock Exchange (NYSE: LLY) as an S&P 500 Health Care component — discovering, developing, and commercializing medicines across diabetes, obesity, oncology, immunology, and neuroscience through approximately 43,000 employees worldwide. In fiscal year 2024, Eli Lilly reported revenues of $45.1 billion (+32% year-over-year) — driven by the historic commercial launch of Mounjaro (tirzepatide for type 2 diabetes, $11.4B revenue) and Zepbound (tirzepatide for obesity and obstructive sleep apnea, $4.9B revenue) — making Eli Lilly one of the fastest-growing large pharmaceutical companies in history and elevating its market capitalization above $700 billion at peak 2024 valuation, briefly making Lilly the most valuable healthcare company globally. CEO Dave Ricks' strategic investment in tirzepatide manufacturing capacity — committing $18+ billion to new US manufacturing sites in Indiana, Wisconsin, and North Carolina — reflects Lilly's execution of unprecedented pharmaceutical demand that has consistently outpaced supply since Mounjaro's 2022 approval and Zepbound's 2023 FDA approval for obesity. The GLP-1/GIP dual agonist mechanism (tirzepatide activates both GLP-1 and GIP incretin receptors, versus semaglutide's single GLP-1 activation) produces superior efficacy results — SURMOUNT-1 trial showing 22.5% average body weight loss with tirzepatide versus 15% with semaglutide (Ozempic/Wegovy) — establishing tirzepatide as the most effective approved obesity pharmacotherapy.

Full profile
Apple logo

Apple

LeaderConsumer Electronics

Consumer Technology

NASDAQ-listed (AAPL) world's most valuable company at $391B revenue with iPhone, Mac, and $25B+ App Store; Apple Intelligence AI and Vision Pro spatial computing competing across smartphones, PC, wearables, and services.

AI VisibilityBeta
Overall Score
A91
Category Rank
#1 of 1
AI Consensus
63%
Trend
stable
Per Platform
ChatGPT
98
Perplexity
89
Gemini
88

About

Apple Inc. is a Cupertino, California-based technology company — listed on NASDAQ (NASDAQ: AAPL) and the world's most valuable company by market capitalization at $3+ trillion — designing and manufacturing consumer electronics (iPhone, Mac, iPad, Apple Watch, AirPods, Apple Vision Pro), operating system software (iOS, macOS, watchOS, visionOS), and digital services (App Store, Apple Music, iCloud, Apple TV+, Apple Pay, Apple Arcade) through a vertically integrated hardware-software-services model that generates unparalleled ecosystem lock-in and customer loyalty. Founded by Steve Jobs, Steve Wozniak, and Ronald Wayne in 1976, Apple generated $391 billion in revenue in fiscal year 2024 with 66% iPhone contribution.

Full profile

AI Visibility Head-to-Head

88
Overall Score
91
#125
Category Rank
#1
51
AI Consensus
63
stable
Trend
stable
89
ChatGPT
98
79
Perplexity
89
99
Gemini
88
90
Claude
82
80
Grok
94

Capabilities & Ecosystem

Capabilities

Only Apple
Consumer Technology
Apple is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.